Skip to main content
Dr John Ingram

Dr John Ingram

Clinical Senior Lecturer

School of Medicine

Improving the care of people with hidradenitis suppurativa is my principal research and clinical focus within dermatology. Hidradenitis suppurativa (HS) is a neglected, painful chronic inflammatory skin disease, characterised by recurrent skin boils in flexural sites, producing a large impact on quality of life and affecting about 1% of the adult European population.

I run one of the few dedicated HS clinics in the UK and champion a multi-disciplinary team approach to HS care. My aim is to conduct HS clinical trials to improve patient outcomes, with the support of the UK Dermatology Clinical Trials Network and other collaborative groups. As part of laying the foundations for HS trials, I led the Cochrane review of Interventions for HS and chaired a HS Priority Setting Partnership with support from the James Lind Alliance.

My research to investigate HS epidemiology, impact and outcome measures is supported by a five year Health Fellowship from Health and Care Research Wales. I am also leading the British Association of Dermatologists guideline development group for HS.

In terms of international roles, I am Editor-in-Chief of the British Journal of Dermatology, ranked 3 out of the 66 dermatology journals.

Education & Qualifications

FRCP(Derm) Medicine Royal College of Physicians 2017
FAcadMedEd Medical Education Academy of Medical Educators 2014
MSc Medical Education Cardiff University 2012
Certificate of Completion of Training Dermatology General Medical Council 2011
DM (Oxon) Medicine Oxford University 2008
MA Physiological Science Oxford University 2004
MRCP (UK) Medicine Royal College of Physicians 2002
BM BCh Medicine Oxford University 1999
BA Physiological Science Oxford University 1996

Career Overview

My present appointment is Senior Clinical Lecturer, Cardiff University & Honorary Consultant Dermatologist, Cardiff & Vale University Health Board (2013 - present).

Previously I trained in dermatology on the South Wales Training Rotation and worked for 12 months in dermatology and general medicine in Australia. I performed my DM doctoral studies in Cardiff after completing my SHO medical rotation in South Wales and undertook all of my undergraduate medical training at Oxford University.

Professional memberships

Grant Advisory Committees

  • Member of Health and Care Research Wales Research for Patient and Public Benefit Funding Board
  • Member of British Skin Foundation Large Grant Advisory Committee
  • External peer reviewer for Psoriasis Association annual research grant awards

Examination Boards

  • Royal College of Physicians (RCP) Dermatology Specialty Certificate Examination Board member

UK Advisory Roles

  • British Association of Dermatologists (BAD) representative for NICE STA of adalimumab for hidradenitis suppurativa
  • NICE Evidence Resources Reference Panel member - dual RCP & BAD representative
  • Medical Adviser for Hidradenitis Suppurativa Trust, the main HS charity in the UK
  • UK Department of Work & Pensions Adviser regarding HS disability

UK Dermatology Clinical Trials Network (UK DCTN)

  • Steering Committee member

All Wales Roles

  • Health and Care Research Wales Dermatology Lead

Speaking engagements


  • UK Dermatology Clinical Trials Network Evidence Based Update meeting. “HS Guidelines from the BAD.” Nottingham, UK.
  • Symposium on Hidradenitis Suppurativa Advances. “UK guidelines for HS Management.” Toronto.


  • SID Annual Meeting Residents Retreat. Invited speaker: “Publishing a manuscript.” Portland, Oregon.
  • British Association of Dermatologists Annual Meeting. Invited speaker and session chair. “Biologic Interventions for Hidradenitis Suppurativa.” Liverpool, UK 2017.














Medical undergraduates

  • Admissions interview panel chairperson
  • Dermatology clinical tutor
  • Academic mentor
  • Finals examiner

Dermatology postgraduates

  • Lecturer and examiner for Diploma & MSc in Clinical Dermatology
  • Lecturer for MSc course and intercalated BSc medical undergraduate course in Medical Education
  • Lead for Diploma in Practical Dermatology 2012–14. In this role I modularised the course, blueprinted assessments to level 7 learning outcomes and moved the Virtual Learning Environment to the Cardiff University Blackboard provider

All Wales dermatology training scheme

  • Co-opted member of Specialty Advisory Committee with responsibility for research skills

Hidradenitis suppurativa

My main research interest is hidradenitis suppurativa (HS), a relatively common, painful chronic inflammatory skin condition which can have a large impact on quality of life and may be difficult to treat. As a result, more than 50 medical and surgical interventions have been tried and our recent Cochrane review showed that the evidence base for most interventions is relatively poor, making treatment decisions challenging.

I am building the foundations to perform rigorous clinical trials to improve the care of people with HS. Our HS Priority Setting Partnership between HS patients and clinicians ( highlighted the therapy areas that are most in need of more evidence. My five year Health Fellowship from Health and Care Research Wales (HCRW) is designed to provide better measures of the impact and epidemiology of HS, to demonstrate the degree of unmet need. In addition, I am undertaking a consensus project for HS outcome measures (HISTORIC), in collaboration with the CSG-COUSIN and IDEOM international groups, to improve the definition of treatment success or failure for future clinical trials.

I am also a member of the European Reference Network for skin diseases (ERN-Skin) regarding HS (


I am Chief Investigator of INDUCE, a HCRW-funded trial investigating “Point-of-care tests to assist antibiotic prescribing decisions for diabetic foot ulcer infections”. The study has also developed an online educational tool: The aim is to develop a composite test of inflammatory markers to improve the diagnosis of diabetic foot ulcer infections in the community.

Research Students

  • Dr Ausama Atwan. MD programme. "Optimising Psoriasis Care Pathways."

External profiles